alzheimers | CARLAT PUBLISHING

CLINICAL UPDATE

Low-Dose Lithium to Delay Dementia?

September 1, 2022

James Phelps, MD. Psychiatrist Emeritus, Samaritan Mental Health, Corvallis, OR. Medical Director, PsychEducation.org. Dr. Phelps, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Current medications for dementia do little more than temporarily slow the cognitive decline, but new evidence suggests that tiny doses of lithium can significantly delay the onset.

Structural Brain Changes: How Imaging Affects Management of Late-Life Psychiatric Conditions

July 1, 2022

Oluwole Jegede, MD, PhD

Olusola Alade Ajilore, MD, PhD

Associate professor, Department of Psychiatry, University of Illinois College of Medicine, Chicago, IL.

Dr. Ajilore, expert for this educational activity, is an employee of KeyWise AI and an advisor for Embodied Labs, Blueprint, and Sage Therapeutics. All of the relevant financial relationships listed for this individual have been mitigated.

When does imaging change management? Dr. Ajilore describes when to order neuroimaging and what to look for. He walks us through various imaging modalities (both structural and functional) that can point us toward the correct diagnosis.

Q&A

Treating Agitation in Patients with Dementia

September 13, 2021

Eran Metzger, MD

Eran Metzger, MD

Medical Director of Psychiatry, Hebrew SeniorLife, Boston, MA. Assistant Professor of Psychiatry, Harvard Medical School, Boston, MA.

Dr. Metzger has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The behavioral and psychological symptoms of dementia can be challenging to manage. Dr. Metzger discusses his approach in the diagnosis and treatment of agitated patients with dementia.